A Case of Paraphilia with Osteoporosis and Administered with Depot Leuprorelin.

Abstract

Paraphilia is a complex psychological and psychiatric disorder that has been difficult to treat. Leuprorelin has been used as one of the therapeutic methods for paraphilia. Leuprorelin administration could change insulin resistance and accelerate bone loss. The case study in this work was a 59-year-old man who visited a hospital with the chief complaints of frotteuristic behaviors in public places, a continuous increase in sexual desire, and sexual molestation behavior that started in 2007. We injected leuprorelin (3.6 mg) intramuscularly every month for this patient with paraphilia and comorbidities of osteoporosis and hyperthyroidism. The clinical global impression (CGI), Sex Addiction Screening Test (SAST), Wilson Sex Fantasy Questionnaire (WSFQ), physical examination, and laboratory tests were performed. After 12 months of leuprorelin injection for paraphilia, we found a significant improvement in abnormal sexual behavior/desire without aggravation of osteoporosis/hyperthyroidism. Gonadotrophin-Releasing Hormone (GnRH) analogs could be used as alternative or supplementary treatment methods for paraphilia with osteoporosis/hyperthyroidism.

• Authors: Dohee Kim, Kyoung Min Kim, Myung Ho Lim
• Journal: Medicina (Kaunas, Lithuania) (Medicina (Kaunas)) Vol. 55 Issue 10 (Oct 20 2019) ISSN: 1648-9144 [Electronic] Switzerland
• PMID: 31635190 (Publication Type: Case Reports)

Chemical References

• Delayed-Action Preparations
• Leuprolide

Topics

• Delayed-Action Preparations (pharmacology, therapeutic use)
• Humans
• Leuprolide (adverse effects, pharmacology, therapeutic use)
• Male
• Middle Aged
• Osteoporosis (etiology)
• Paraphilic Disorders (drug therapy)